UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Multifunctional LNA Oligonucleotide-Based Strategy Blocks AR Expression and Transactivation Activity in PCa Cells

Molecular therapy. Nucleic acids, 2021-03, Vol.23, p.63-75

2021

Volltextzugriff (PDF)

Mutations in COA3 cause isolated complex IV deficiency associated with neuropathy, exercise intolerance, obesity, and short stature

Journal of medical genetics, 2015-03, Vol.52 (3), p.203-207

2015

Volltextzugriff (PDF)

Germline Chromothripsis Driven by L1-Mediated Retrotransposition and Alu/Alu Homologous Recombination

Human mutation, 2016-04, Vol.37 (4), p.385-395

2016

Volltextzugriff (PDF)

Functional characterization of BRCA1 gene variants by mini-gene splicing assay

European journal of human genetics : EJHG, 2014-12, Vol.22 (12), p.1362-1368

2014

Volltextzugriff (PDF)

Molecular Composition of IMP1 Ribonucleoprotein Granules

Molecular & cellular proteomics, 2007-05, Vol.6 (5), p.798-811

2007

Volltextzugriff (PDF)

RNA-binding IMPs promote cell adhesion and invadopodia formation

The EMBO journal, 2006-04, Vol.25 (7), p.1456-1468

2006

Volltextzugriff (PDF)

Next-generation sequencing: proof of concept for antenatal prediction of the fetal Kell blood group phenotype from cell-free fetal DNA in maternal plasma

Transfusion (Philadelphia, Pa.), 2013-11, Vol.53 (11pt2), p.2892-2898

2013

Volltextzugriff (PDF)

IMP3 RNP Safe Houses Prevent miRNA-Directed HMGA2 mRNA Decay in Cancer and Development

Cell reports (Cambridge), 2014-04, Vol.7 (2), p.539-551

2014

Volltextzugriff (PDF)

Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancer

Breast cancer research and treatment, 2016-01, Vol.155 (2), p.215-222

2016

Volltextzugriff (PDF)

Personalized oncology: genomic screening in phase 1

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2014-08, Vol.122 (8), p.723-733

2014

Volltextzugriff (PDF)

Abstract 3140: Differential clonal selection in tumor tissue and cell-free DNA from a neratinib-treated refractory breast cancer patient harboring an activating ERBB2 (HER2) mutation

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3140-3140

2016

Volltextzugriff (PDF)

Actionable targets in recurrent bile duct and pancreatic cancer in a prospective cohort of patients evaluated by whole exome sequencing and SNP array analysis

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e23256-e23256

2016

Volltextzugriff (PDF)

Dynamics of mutant BRAF V600E in free circulating DNA (fcDNA) of non-melanoma cancer patients (pts) in response to treatment with BRAF and MEK/EGFR inhibitors

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.11531-11531

2016

Volltextzugriff (PDF)

Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members

Breast cancer research and treatment, 2012-04, Vol.132 (3), p.1009-1023

2012

Volltextzugriff (PDF)

Copenhagen prospective personalized oncology (CoPPO): Sequencing and array-based pipeline for selection of patients to phase 1 studies

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.11097-11097

2014

Volltextzugriff (PDF)

Molecular profiling of tumour budding to implicate TGF-β mediated epithelial-mesenchymal transition as a therapeutic target

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.6059-6059

2015

Volltextzugriff (PDF)

Genome‐wide identification of genes required for growth of Saccharomyces cerevisiae under ethanol stress

Yeast (Chichester, England), 2006-04, Vol.23 (5), p.351-359

2006

Volltextzugriff (PDF)

Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families

Breast cancer research and treatment, 2009-05, Vol.115 (2), p.315-323

2009

Volltextzugriff (PDF)

Identification of a breast cancer family double heterozygote for RAD51C and BRCA2 gene mutations

Familial cancer, 2015-03, Vol.14 (1), p.129-133

2015

Volltextzugriff (PDF)

Identification of a novel BRCA1 nucleotide 4803delCC/c.4684delCC mutation and a nucleotide 249T>A/c.130T>A (p.Cys44Ser) mutation in two Greenlandic Inuit families: implications for genetic screening of Greenlandic Inuit families with high risk for breast and/or ovarian cancer

Breast cancer research and treatment, 2010-11, Vol.124 (1), p.259-264

2010

Volltextzugriff (PDF)

common Greenlandic Inuit BRCA1 RING domain founder mutation

Breast cancer research and treatment, 2009-05, Vol.115 (1), p.69-76

2009

Volltextzugriff (PDF)

The silent mutation nucleotide 744 G1A, Lys172Lys, in exon 6 of BRCA2 results in exon skipping

Breast cancer research and treatment, 2010-02, Vol.119 (3), p.547-550

2010

Volltextzugriff (PDF)

Novel de novo BRCA2 mutation in a patient with a family history of breast cancer

BMC medical genetics, 2008-07, Vol.9 (1), p.58-58

2008

Volltextzugriff (PDF)

Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations

Familial cancer, 2010-09, Vol.9 (3), p.283-287

2010

Volltextzugriff (PDF)

Enhanced peptide secretion by gene disruption of CYM1, a novel protease in Saccharomyces cerevisiae

European journal of biochemistry, 2004-12, Vol.271 (23‐24), p.4788-4797

2004

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Multifunctional LNA Oligonucleotide-Based Strategy Blocks AR Expression and Transactivation Activity in PCa Cells

Mutations in COA3 cause isolated complex IV deficiency associated with neuropathy, exercise intolerance, obesity, and short stature

Germline Chromothripsis Driven by L1-Mediated Retrotransposition and Alu/Alu Homologous Recombination

Functional characterization of BRCA1 gene variants by mini-gene splicing assay

Molecular Composition of IMP1 Ribonucleoprotein Granules

RNA-binding IMPs promote cell adhesion and invadopodia formation

Next-generation sequencing: proof of concept for antenatal prediction of the fetal Kell blood group phenotype from cell-free fetal DNA in maternal plasma

IMP3 RNP Safe Houses Prevent miRNA-Directed HMGA2 mRNA Decay in Cancer and Development

Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancer

Personalized oncology: genomic screening in phase 1

Abstract 3140: Differential clonal selection in tumor tissue and cell-free DNA from a neratinib-treated refractory breast cancer patient harboring an activating ERBB2 (HER2) mutation

Actionable targets in recurrent bile duct and pancreatic cancer in a prospective cohort of patients evaluated by whole exome sequencing and SNP array analysis

Dynamics of mutant BRAF V600E in free circulating DNA (fcDNA) of non-melanoma cancer patients (pts) in response to treatment with BRAF and MEK/EGFR inhibitors

Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members

Copenhagen prospective personalized oncology (CoPPO): Sequencing and array-based pipeline for selection of patients to phase 1 studies

Molecular profiling of tumour budding to implicate TGF-β mediated epithelial-mesenchymal transition as a therapeutic target

Genome‐wide identification of genes required for growth of Saccharomyces cerevisiae under ethanol stress

Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families

Identification of a breast cancer family double heterozygote for RAD51C and BRCA2 gene mutations

Identification of a novel BRCA1 nucleotide 4803delCC/c.4684delCC mutation and a nucleotide 249T>A/c.130T>A (p.Cys44Ser) mutation in two Greenlandic Inuit families: implications for genetic screening of Greenlandic Inuit families with high risk for breast and/or ovarian cancer

common Greenlandic Inuit BRCA1 RING domain founder mutation

The silent mutation nucleotide 744 G1A, Lys172Lys, in exon 6 of BRCA2 results in exon skipping

Novel de novo BRCA2 mutation in a patient with a family history of breast cancer

Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations

Enhanced peptide secretion by gene disruption of CYM1, a novel protease in Saccharomyces cerevisiae

Suchergebnisse filtern